Ironwood Pharmaceuticals Inc’s filing revealed that its Director McHugh Julie unloaded Company’s shares for reported $0.14 million on Jun 10 ’24. In the deal valued at $6.29 per share,22,766 shares were sold. As a result of this transaction, McHugh Julie now holds 139,528 shares worth roughly $0.81 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Moukheibir Catherine sold 35,574 shares, generating $235,144 in total proceeds. Upon selling the shares at $6.61, the Director now owns 48,633 shares.
Before that, Moukheibir Catherine sold 44,426 shares. Ironwood Pharmaceuticals Inc shares valued at $282,549 were divested by the Director at a price of $6.36 per share. As a result of the transaction, Moukheibir Catherine now holds 84,207 shares, worth roughly $0.49 million.
Craig Hallum initiated its Ironwood Pharmaceuticals Inc [IRWD] rating to a Buy in a research note published on January 17, 2024; the price target was $21. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in mid December with a ‘”an Overweight”‘ rating. Jefferies began covering IRWD with “Buy” recommendation on November 09, 2023. JMP Securities started covering the stock on September 28, 2023. It rated IRWD as “a Mkt outperform”.
Price Performance Review of IRWD
On Friday, Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] saw its stock fall -2.51% to $5.83. Over the last five days, the stock has lost -8.19%. Ironwood Pharmaceuticals Inc shares have fallen nearly -49.04% since the year began. Nevertheless, the stocks have fallen -47.24% over the past one year. While a 52-week high of $15.70 was reached on 02/14/24, a 52-week low of $5.76 was recorded on 06/14/24. SMA at 50 days reached $7.16, while 200 days put it at $9.76. A total of 2.35 million shares were traded, compared to the trading of 2.0 million shares in the previous session.
Levels Of Support And Resistance For IRWD Stock
The 24-hour chart illustrates a support level at 5.70, which if violated will result in even more drops to 5.57. On the upside, there is a resistance level at 5.95. A further resistance level may holdings at 6.07. The Relative Strength Index (RSI) on the 14-day chart is 35.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.03%. Stochastics %K at 29.44% indicates the stock is a holding.
The most recent change occurred on September 02, 2022 when CapitalOne began covering the stock and recommended ‘”an Overweight”‘ rating along with a $15 price target.
